| Therapeutic drug monitoring of lacosamide in Norway: focus on pharmacokinetic variability, efficacy and tolerability T Svendsen, E Brodtkorb, A Baftiu, ML Burns, SI Johannessen, ... Neurochemical research 42, 2077-2083, 2017 | 51 | 2017 |
| Age‐specific prevalence of epilepsy in Oppland County, Norway T Svendsen, M Lossius, KO Nakken Acta neurologica scandinavica 116 (5), 307-311, 2007 | 30 | 2007 |
| The impact of pharmacokinetic interactions with eslicarbazepine acetate versus oxcarbazepine and carbamazepine in clinical practice CJ Landmark, T Svendsen, J Dinarevic, RF Kufaas, A Reimers, ... Therapeutic Drug Monitoring 38 (4), 499-505, 2016 | 27 | 2016 |
| Pharmacokinetic variability, efficacy and tolerability of eslicarbazepine acetate–A national approach to the evaluation of therapeutic drug monitoring data and clinical outcome T Svendsen, E Brodtkorb, A Reimers, E Molden, E Sætre, SI Johannessen, ... Epilepsy Research 129, 125-131, 2017 | 23 | 2017 |
| Sexual function in people with epilepsy: Similarities and differences with the general population O Henning, C Johannessen Landmark, B Træen, T Svendsen, A Farmen, ... Epilepsia 60 (9), 1984-1992, 2019 | 17 | 2019 |
| Effect and tolerability of perampanel in patients with drug-resistant epilepsy IMB Lossius, T Svendsen, HF Sødal, K Kjeldstadli, MI Lossius, KO Nakken, ... Epilepsy & Behavior 119, 107965, 2021 | 14 | 2021 |
| Langtidsbivirkninger av antiepileptika T Svendsen, KÅ Alfstad, MI Lossius, KO Nakken Tidsskrift for Den norske legeforening, 2016 | 8 | 2016 |
| Efficacy, tolerability and pharmacokinetic variability of brivaracetam in adults with difficult-to-treat epilepsy T Svendsen, E Brodtkorb, HL Linge, ML Burns, SI Johannessen, ... Epilepsy Research 183, 106946, 2022 | 4 | 2022 |
| Antiepileptic drugs and congenital malformations KO Nakken, KM Lillestølen, E Brodtkorb, T Svendsen, KJ Haggag, ... Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin, ny …, 2014 | 4 | 2014 |
| Clinical experience combined with therapeutic drug monitoring of lacosamide T Svendsen, E Brodtkorb, A Baftiu, MI Lossius, KO Nakken, ... Acta Neurologica Scandinavica 141 (4), 279-286, 2020 | 3 | 2020 |
| Antiepileptika og medfødte misdannelser KO Nakken, KM Lillestølen, E Brodtkorb, T Svendsen, KJ Haggag, ... Tidsskrift for Den norske legeforening, 2014 | 3 | 2014 |
| Topiramate--a new antiepileptic agents T Svendsen, SI Johannessen, KO Nakken Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin, ny …, 2000 | 3 | 2000 |
| Risk of major congenital malformations and exposure to antiseizure medication monotherapy D Battino, T Tomson, E Bonizzoni, J Craig, E Perucca, A Sabers, ... JAMA neurology, 2024 | 1 | 2024 |
| Comparison of lacosamide treatment in patients with and without intellectual disability CJ Landmark, T Svendsen, E Brodtkorb, A Baftiu, ML Burns, ... Epilepsia 59, S173-S174, 2018 | 1 | 2018 |
| The impact of pharmacokinetic interactions with eslicarbazepine acetate versus oxcarbazepine and carbamazepine in clinical practice (vol 38, pg 499, 2016) JC Landmark, T Svendsen, J Dinarevic, RF Kufaas, A Reimers, ... THERAPEUTIC DRUG MONITORING 38 (6), 816-816, 2016 | 1 | 2016 |
| Topiramat–et nytt antiepileptikum T Svendsen, SI Johannessen, KO Nakken Tidsskrift for Den norske legeforening, 2000 | 1 | 2000 |
| The fair-haired giant KO Nakken, T Svendsen, E Hem Tidsskrift for Den norske legeforening, 2022 | | 2022 |
| Den blonde kjempe KO Nakken, T Svendsen, E Hem | | 2022 |
| Efficacy and Tolerability of Brivaracetam in Patients with Refractory Epilepsy. An Open Prospective Follow-Up Study T Svendsen, MI Lossius, KO Nakken, A Baftiu, SI Johannessen, ... EPILEPSIA 59, S275-S275, 2018 | | 2018 |
| EFFICACY AND TOLERABILITY OF LACOSAMIDE AS ADD-ON TREATMENT IN PATIENTS WITH REFRACTORY EPILEPSY AND INTELLECTUAL DISABILITY T Svendsen, KO Nakken, MI Lossius, SI Johannessen, E Brodtkorb, ... EPILEPSIA 58, S104-S105, 2017 | | 2017 |
